Free Trial
NASDAQ:ERNA

Eterna Therapeutics 5/11/2023 Earnings Report

Eterna Therapeutics logo
$0.20 0.00 (-2.22%)
Closing price 04:00 PM Eastern
Extended Trading
$0.20 0.00 (-0.51%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eterna Therapeutics EPS Results

Actual EPS
-$1.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Eterna Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Eterna Therapeutics Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Eterna Therapeutics' next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules.

Conference Call Resources

Eterna Therapeutics Earnings Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
Ernexa Therapeutics Closes New Funding Round
Eterna changes name to Ernexa Therapeutics
See More Eterna Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Eterna Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eterna Therapeutics and other key companies, straight to your email.

About Eterna Therapeutics

Eterna Therapeutics (NASDAQ:ERNA), a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

View Eterna Therapeutics Profile

More Earnings Resources from MarketBeat